Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
+5.1M
-
Total reported value, excl. options
-
$223M
-
Value change
-
+$51.5M
-
Put/Call ratio
-
0.06
-
Number of buys
-
48
-
Number of sells
-
-25
-
Price
-
$10.13
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2023
81 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q2 2023.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
of 44.5M outstanding shares and own 49.52% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.11M shares), ORBIMED ADVISORS LLC (2.84M shares), First Light Asset Management, LLC (1.73M shares), AIGH Capital Management LLC (1.66M shares), Opaleye Management Inc. (1.58M shares), BlackRock Inc. (1.01M shares), Pentwater Capital Management LP (879K shares), VANGUARD GROUP INC (869K shares), NEXT CENTURY GROWTH INVESTORS LLC (775K shares), and Velan Capital Investment Management LP (746K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.